A Closer Look at the Bad Deal Trial: Beyond Clinical Equipoise

Some commentators have recently proposed that “clinical equipoise,” although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects—”bad deal trials”—could...

Full description

Saved in:  
Bibliographic Details
Main Author: Jansen, Lynn A. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Published: 2005
In: The Hastings Center report
Year: 2005, Volume: 35, Issue: 5, Pages: 29-36
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002c 4500
001 1937542963
003 DE-627
005 20251002055639.0
007 cr uuu---uuuuu
008 251002s2005 xx |||||o 00| ||eng c
024 7 |a 10.1353/hcr.2005.0077  |2 doi 
035 |a (DE-627)1937542963 
035 |a (DE-599)KXP1937542963 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Jansen, Lynn A.  |e VerfasserIn  |4 aut 
245 1 2 |a A Closer Look at the Bad Deal Trial: Beyond Clinical Equipoise 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Some commentators have recently proposed that “clinical equipoise,” although widely accepted, is not necessary for morally acceptable research on human subjects. If this concept is rejected, however, we may find that trials not in the best medical interests of their subjects—”bad deal trials”—could be justified. To avoid exploiting participants, we must find a way to distribute the risks fairly, even if it means embracing radical changes in the way clinical research is conducted. 
773 0 8 |i Enthalten in  |a Hastings Center  |t The Hastings Center report  |d Malden, Mass. : Wiley, 1971  |g 35(2005), 5, Seite 29-36  |h Online-Ressource  |w (DE-627)341346551  |w (DE-600)2067369-3  |w (DE-576)258761822  |x 1552-146X  |7 nnas 
773 1 8 |g volume:35  |g year:2005  |g number:5  |g pages:29-36 
856 4 0 |u https://doi.org/10.1353/hcr.2005.0077  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1353/hcr.2005.0077  |x Verlag  |z lizenzpflichtig  |3 Volltext 
912 |a NOMM 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4779669162 
LOK |0 003 DE-627 
LOK |0 004 1937542963 
LOK |0 005 20251002055639 
LOK |0 008 251002||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2025-09-26#2048E0A5D7156F9221576603FB582257825998A5 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixrk  |a ixzs  |a zota  |a tiep 
ORI |a TA-MARC-ixtheoa001.raw